Get started
Author

Manuel González Barón

Observed names: González Barón, Manuel, M Gonzalez Baron, M Gonzalez Barón, M González Barón, M González Barón, M. Baron, M. G. Baron, M. G. Barón, M. Gonzalez Baron, M. Gonzalez Barón, M. González Barón, M.González Barón, Manuel Barón, Manuel Gonzalez Baron, Manuel Gonzàlez Barón, Manuel González Barón.
Observed institutions: Consejo Superior de Investigaciones Científicas, Hospital Universitario La Paz, University of Oxford, Hospital Universitario Virgen Macarena, Hospital Universitari Sant Joan D'Alacant, Hospital Universitario de Gran Canaria Doctor Negrín, Marqués de Valdecilla University Hospital, Hospital Universitario Fundación Alcorcón, Hospital Universitario 12 De Octubre, Hospital La Paz Institute for Health Research, Hospital Universitario Príncipe de Asturias, Hospital San Pedro de Alcántara, Hospital Obispo Polanco, Hospital Virgen de la Salud, Hospital Arnau de Vilanova, Hospital Central de la Cruz Roja San José y Santa Adela, Hospital General Universitario De Valencia, Hospital de Sagunto, Hospital Xeral Calde, MD Anderson Cancer Center Madrid, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Universitario Infanta Sofía, Universidad Autónoma de Madrid
OpenAlex ID: A5111884665
Classification of anticancer drugs—a new system based on therapeutic targets
2003 · Enrique Espinosa, Pilar Zamora, et al. · Cancer Treatment Reviews · 197
Oxycodone: a pharmacological and clinical review
2007 · A. Ordóñez Gallego, M. González Barón, et al. · Clinical & Translational Oncology · 150
Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer
1995 · E. Espinosa, J. Feliu, et al. · Lung Cancer · 117
Efficacy, tolerability and management of raltitrexed (Tomudex™) monotherapy in patients with advanced colorectal cancer
2002 · D. Cunningham, J. Zalcberg, et al. · European Journal of Cancer · 69
EGFR and colon cancer: a clinical view
2008 · Javier de Castro-Carpeño, Cristóbal Belda-Iniesta, et al. · Clinical & Translational Oncology · 68
Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy
2002 · J. Feliu, J. Calvillo, et al. · Annals of Oncology · 65
Doctors also suffer when giving bad news to cancer patients
1996 · E. Espinosa, M. González Barón, et al. · Supportive Care in Cancer · 61
Breast Cancer Prognosis Determined by Gene Expression Profiling: A Quantitative Reverse Transcriptase Polymerase Chain Reaction Study
2005 · E. Espinosa, J.A. Fresno Vara, et al. · Journal of Clinical Oncology · 58
Employment in a cohort of breast cancer patients
2008 · R. Molina Villaverde, J. Feliu Batlle, et al. · Occupational Medicine · 53
PDF
Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
2004 · N Batista, G Perez-Manga, et al. · British Journal of Cancer · 48
PDF
Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia
2006 · César Gómez Raposo, Álvaro Pinto Marín, et al. · Clinical & Translational Oncology · 44
Renal Tolerance to Cisplatin in Patients 70 Years and Older
2001 · Antonio Cubillo, Maria Cornide, et al. · American Journal of Clinical Oncology · 37
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study
2005 · E Van Cutsem, L Dirix, et al. · British Journal of Cancer · 36
PDF
Clinical features of pharyngeal cancer: a retrospective study of 258 consecutive patients
2001 · A. Escribano Uzcudun, P. Bravo Fernández, et al. · The Journal of Laryngology & Otology · 36
Nutrition and pharyngeal cancer: Results from a case‐control study in Spain
2002 · Ana Escribano Uzcudun, Iñaki Rabanal Retolaza, et al. · Head & Neck · 35
An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer
2010 · Iker Sánchez-Navarro, Angelo Gámez-Pozo, et al. · BMC Cancer · 34
PDF
Role of anti-Her-2 therapy in bladder carcinoma
2010 · Álvaro Pinto Marín, Enrique Espinosa Arranz, et al. · Journal of Cancer Research and Clinical Oncology · 34
Hematopoietic Growth Factors
2006 · P Zamora Auñón, M González Barón · Springer eBooks · 34
Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas
2002 · J. Feliu, R. Mel, et al. · Annals of Oncology · 34
New screening method for lung cancer by detecting volatile organic compounds in breath
2007 · C. Belda-Iniesta, J. de Castro Carpeño, et al. · Clinical & Translational Oncology · 32
Raltitrexed in the treatment of elderly patients with advanced colorectal cancer
2002 · J Feliu, J.R Mel, et al. · European Journal of Cancer · 30
Transcriptional Targeting for Ovarian Cancer Gene Therapy
2001 · E. Casado, D.M. Nettelbeck, et al. · Gynecologic Oncology · 30
Molecular biology of malignant gliomas
2006 · Cristóbal Belda-Iniesta, Javier de Castro Carpeño, et al. · Clinical & Translational Oncology · 29
Molecular biology of pancreatic cancer
2008 · Cristóbal Belda-Iniesta, Inmaculada Ibáñez de Cáceres, et al. · Clinical & Translational Oncology · 27
Oral chemotherapy: potential benefits and limitations
2004 · Jaime Feliu Batlle, Enrique Espinosa Arranz, et al. · Clinical & Translational Oncology · 25
Works count: 187
Citation count: 2,127
H-index: 25
I10-index: 54
Year
Topic
Type